Inventor
CARLO DENNIS J
US42 patents
⚠️ This page may combine multiple inventors who share the name “CARLO DENNIS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNE RESPONSE CORP INC
20 patentsUS6017543AJan 25, 2000
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC81 citations96
US5928930AJul 27, 1999
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC75 citations96
US5916806AJun 29, 1999
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC69 citations96
US5895650AApr 20, 1999
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC69 citations96
US5885578AMar 23, 1999
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC72 citations96
US5256767AOct 26, 1993
Retroviral antigens
IMMUNE RESPONSE CORP INC104 citations96
US6069133AMay 30, 2000
Targeted delivery of genes encoding interferon
IMMUNE RESPONSE CORP INC87 citations95
US5853725ADec 29, 1998
Prevention and treatment of retroviral disease
IMMUNE RESPONSE CORP INC50 citations95
US6221352B1Apr 24, 2001
Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells
IMMUNE RESPONSE CORP INC34 citations92
US6207645B1Mar 27, 2001
Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC21 citations92
US6159470ADec 12, 2000
Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC17 citations92
US6090387AJul 18, 2000
Vaccination and methods against diseases resulting from pathogenic responses
IMMUNE RESPONSE CORP INC26 citations92
US5985552ANov 16, 1999
Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC24 citations92
US5837246ANov 17, 1998
Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC18 citations92
US5612035AMar 18, 1997
Vaccination against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC49 citations92
US6464978B1Oct 15, 2002
Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC33 citations91
US6331525B1Dec 18, 2001
Targeted delivery of genes encoding interferon
IMMUNE RESPONSE CORP INC23 citations89
US6413516B1Jul 2, 2002
Peptides and methods against psoriasis
IMMUNE RESPONSE CORP INC15 citations79
US6007815ADec 28, 1999
Anti-idiotype vaccination against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC7 citations73
US5861164AJan 19, 1999
Vaccination against diseases resulting from pathogenic responses by specific T cell populations
IMMUNE RESPONSE CORP INC14 citations73
MERCK & CO INC
14 patentsUS4413057ANov 1, 1983
Group B streptococcal capsular polysaccharides
MERCK & CO INC37 citations89
US4123520AOct 31, 1978
Method for preparing high molecular weight meningococcal Group C vaccine
MERCK & CO INC27 citations81
US4285931AAug 25, 1981
E. coli enterotoxin vaccine for veterinary and human use
MERCK & CO INC25 citations80
US4220584ASep 2, 1980
E. coli enterotoxin vaccine for veterinary and human use
MERCK & CO INC19 citations80
US4264764AApr 28, 1981
Meningitis vaccine
MERCK & CO INC8 citations73
US4235994ANov 25, 1980
High molecular weight meningococcal group C vaccine and method for preparation thereof
MERCK & CO INC11 citations73
US4203970AMay 20, 1980
Swine atropic rhinitis vaccine
MERCK & CO INC8 citations73
US4220638ASep 2, 1980
Antigenic complex from N. Gonorrhoeae
MERCK & CO INC13 citations72
US3978209AAug 31, 1976
Endotoxin free meningococcus polysaccharides
MERCK & CO INC9 citations72
US4407949AOct 4, 1983
Meningitis vaccine
MERCK & CO INC4 citations62
US4307080ADec 22, 1981
Meningitis vaccine
MERCK & CO INC5 citations62
US4250265AFeb 10, 1981
Method of obtaining an antigenic fraction from Bordetella bronchiseptica
MERCK & CO INC2 citations62
US4288557ASep 8, 1981
Antigenic complex from N. gonorrhoeae
MERCK & CO INC5 citations61
US4287173ASep 1, 1981
Vaccine for dental caries
MERCK & CO INC4 citations60
ADAMIS PHARMACEUTICALS CORP
6 patentsUS11027072B2Jun 8, 2021
Emergency devices
ADAMIS PHARMACEUTICALS CORP6 citations79
US11045450B2Jun 29, 2021
Drug compositions
ADAMIS PHARMACEUTICALS CORP1 citations69
US10441575B2Oct 15, 2019
Drug compositions
ADAMIS PHARMACEUTICALS CORP2 citations69
US10137111B2Nov 27, 2018
Drug compositions comprising an anti-parasitic and proton pump inhibitor
ADAMIS PHARMACEUTICALS CORP2 citations69
US11564910B2Jan 31, 2023
Drug compositions
ADAMIS PHARMACEUTICALS CORP1 citations58
US11285192B2Mar 29, 2022
Formulation including a combination of beta-endorphin and adrenocorticotropic hormone
ADAMIS PHARMACEUTICALS CORP0 citations53